These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8950098)

  • 1. 5-HT1A receptor agonist flesinoxan enhances Fos immunoreactivity in rat central amygdala, bed nucleus of the stria terminalis and hypothalamus.
    Compaan JC; Groenink L; van der Gugten J; Maes RA; Olivier B
    Eur J Neurosci; 1996 Nov; 8(11):2340-7. PubMed ID: 8950098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with 5-HT1A receptor agonist flesinoxan attenuates Fos protein in rat hypothalamus.
    Compaan JC; Groenink L; Van der Gugten J; Maes RA; Olivier B
    Eur J Pharmacol; 1997 Apr; 324(2-3):161-8. PubMed ID: 9145767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of serotonergic pathways in mediating the neuronal activity and genetic transcription of neuroendocrine corticotropin-releasing factor in the brain of systemically endotoxin-challenged rats.
    Laflamme N; Feuvrier E; Richard D; Rivest S
    Neuroscience; 1999 Jan; 88(1):223-40. PubMed ID: 10051203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus.
    Laflamme N; Bovetto S; Richard D; Rivest S
    Br J Pharmacol; 1996 Mar; 117(6):1021-34. PubMed ID: 8882592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
    Larsen PJ; Tang-Christensen M; Jessop DS
    Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells.
    Van de Kar LD; Javed A; Zhang Y; Serres F; Raap DK; Gray TS
    J Neurosci; 2001 May; 21(10):3572-9. PubMed ID: 11331386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-Fenfluramine induces serotonin-mediated Fos expression in corticotropin-releasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala.
    Javed A; Kamradt MC; Van de Kar LD; Gray TS
    Neuroscience; 1999 Mar; 90(3):851-8. PubMed ID: 10218785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CRH in the effects of 5-HT-receptor agonists on food intake and metabolic rate.
    Bovetto S; Rouillard C; Richard D
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1231-8. PubMed ID: 8945958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flesinoxan treatment reduces 5-HT1A receptor mRNA in the dentate gyrus independently of high plasma corticosterone levels.
    Sibug RM; Compaan JC; Meijer OC; Van der Gugten J; Olivier B; De Kloet ER
    Eur J Pharmacol; 1998 Jul; 353(2-3):207-14. PubMed ID: 9726650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central administration of cocaine-amphetamine-regulated transcript activates hypothalamic neuroendocrine neurons in the rat.
    Vrang N; Larsen PJ; Kristensen P; Tang-Christensen M
    Endocrinology; 2000 Feb; 141(2):794-801. PubMed ID: 10650962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postsynaptic 5-HT1A receptors mediate 5-hydroxytryptamine release in the amygdala through a feedback to the caudal linear raphe.
    Bosker FJ; Klompmakers A; Westenberg HG
    Eur J Pharmacol; 1997 Aug; 333(2-3):147-57. PubMed ID: 9314028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional activation of CRH neurons and expression of the genes encoding CRH and its receptors in food-deprived lean (Fa/?) and obese (fa/fa) Zucker rats.
    Timofeeva E; Richard D
    Neuroendocrinology; 1997 Nov; 66(5):327-40. PubMed ID: 9387852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine stimulates c-fos expression in hypothalamic vasopressin-, oxytocin-, and corticotropin-releasing hormone-containing neurons.
    Kjaer A; Larsen PJ; Knigge U; Møller M; Warberg J
    Endocrinology; 1994 Jan; 134(1):482-91. PubMed ID: 8275963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous administration of interleukin-1 beta induces Fos-like immunoreactivity in corticotropin-releasing hormone neurons in the paraventricular hypothalamic nucleus of the rat.
    Veening JG; van der Meer MJ; Joosten H; Hermus AR; Rijnnkels CE; Geeraedts LM; Sweep CG
    J Chem Neuroanat; 1993; 6(6):391-7. PubMed ID: 8142074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic activation of CRH neurons in extrahypothalamic regions of the rat brain.
    Matta SG; Valentine JD; Sharp BM
    Endocrine; 1997 Oct; 7(2):245-53. PubMed ID: 9549051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Region-specific immediate-early gene expression following the administration of corticotropin-releasing hormone in virgin and lactating rats.
    Da Costa AP; Kampa RJ; Windle RJ; Ingram CD; Lightman SL
    Brain Res; 1997 Oct; 770(1-2):151-62. PubMed ID: 9372214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
    Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
    J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus.
    Makino S; Gold PW; Schulkin J
    Brain Res; 1994 Sep; 657(1-2):141-9. PubMed ID: 7820612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of the 5-HT 1B/2C receptor agonist mCPP and the 5-HT1A agonist flesinoxan on hypothalamic neuropeptide Y in the rat: evidence that NPY may mediate serotonin's effects on food intake.
    Dryden S; Wang Q; Frankish HM; Williams G
    Peptides; 1996; 17(6):943-9. PubMed ID: 8899812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors.
    Bosker FJ; de Winter TY; Klompmakers AA; Westenberg HG
    J Neurochem; 1996 Jun; 66(6):2546-55. PubMed ID: 8632181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.